Trial Profile
A Retrospective, Cohort study to compare the efficacy of Ticagrelor and Prasugrel for the prevention of Cardiovascular events in patients with acute coronary syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Sep 2018
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor (Primary)
- Indications Acute coronary syndromes; Cardiovascular disorders
- Focus Therapeutic Use
- 21 Sep 2018 New trial record
- 26 Aug 2018 Results presented at the 34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management